GNPX Genprex Inc

Price (delayed)

$0.6902

Market cap

$7.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.54

Enterprise value

-$10.74M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new ...

Highlights
Genprex's equity has soared by 113% from the previous quarter
The company's EPS has surged by 94% YoY and by 51% QoQ
The net income has grown by 12% year-on-year but it has declined by 3.1% since the previous quarter

Key stats

What are the main financial stats of GNPX

GNPX stock price

How has the Genprex stock price performed over time
Intraday
-4.13%
1 week
-13.15%
1 month
-26.5%
1 year
-95.05%
YTD
-60.56%
QTD
-61.87%

Financial performance

How have Genprex's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$16.04M
Net income
-$16.73M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 16% YoY but it fell by 3.4% QoQ
The net income has grown by 12% year-on-year but it has declined by 3.1% since the previous quarter

Price vs fundamentals

How does GNPX's price correlate with its fundamentals

Growth

What is Genprex's growth rate over time

Valuation

What is Genprex stock price valuation
P/E
N/A
P/B
0.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 94% YoY and by 51% QoQ
Genprex's equity has soared by 113% from the previous quarter
The P/B is 89% below the last 4 quarters average of 3.4 and 85% below the 5-year quarterly average of 2.5

Efficiency

How efficient is Genprex business performance
The ROE has soared by 63% YoY and by 47% QoQ
GNPX's ROA has soared by 52% YoY and by 36% from the previous quarter

Dividends

What is GNPX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GNPX.

Financial health

How did Genprex financials performed over time
GNPX's current ratio has surged by 189% year-on-year and by 46% since the previous quarter
Genprex's total assets has surged by 100% QoQ
Genprex's debt is 100% lower than its equity
Genprex's equity has soared by 113% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.